Weller M - Search Results

1

Adenoviral natural born killer gene therapy for malignant glioma.

Naumann U, Schmidt F, Wick W, Frank B, Weit S, Gillissen B, Daniel P, Weller M. Naumann U, et al. Among authors: weller m. Hum Gene Ther. 2003 Sep 1;14(13):1235-46. doi: 10.1089/104303403767740777. Hum Gene Ther. 2003. PMID: 12952595

2

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Cancer Immunol Immunother. 1997 Mar;44(1):55-63. doi: 10.1007/s002620050355. Cancer Immunol Immunother. 1997. PMID: 9111585 Free PMC article.

3

Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?

Weller M, Schmidt C, Roth W, Dichgans J. Weller M, et al. Neurology. 1997 Jun;48(6):1704-9. doi: 10.1212/wnl.48.6.1704. Neurology. 1997. PMID: 9191791

4

Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.

Wagenknecht B, Gulbins E, Lang F, Dichgans J, Weller M. Wagenknecht B, et al. Among authors: weller m. FEBS Lett. 1997 Jun 2;409(1):17-23. doi: 10.1016/s0014-5793(97)00468-7. FEBS Lett. 1997. PMID: 9199495 Free article.

5

Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and beta-lapachone.

Weller M, Winter S, Schmidt C, Esser P, Fontana A, Dichgans J, Groscurth P. Weller M, et al. Int J Cancer. 1997 Nov 27;73(5):707-14. doi: 10.1002/(sici)1097-0215(19971127)73:5<707::aid-ijc16>3.0.co;2-2. Int J Cancer. 1997. PMID: 9398050 Free article.

6

Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.

Roth W, Wagenknecht B, Grimmel C, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Br J Cancer. 1998;77(3):404-11. doi: 10.1038/bjc.1998.64. Br J Cancer. 1998. PMID: 9472635 Free PMC article.

7

CD95 ligand: lethal weapon against malignant glioma?

Weller M, Kleihues P, Dichgans J, Ohgaki H. Weller M, et al. Brain Pathol. 1998 Apr;8(2):285-93. doi: 10.1111/j.1750-3639.1998.tb00154.x. Brain Pathol. 1998. PMID: 9546287 Free PMC article. Review.

8

APO2 ligand: a novel lethal weapon against malignant glioma?

Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. Rieger J, et al. Among authors: weller m. FEBS Lett. 1998 May 1;427(1):124-8. doi: 10.1016/s0014-5793(98)00409-8. FEBS Lett. 1998. PMID: 9613612 Free article.

9

Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells.

Roth W, Wagenknecht B, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. J Neuroimmunol. 1998 Jul 1;87(1-2):121-9. doi: 10.1016/s0165-5728(98)00079-4. J Neuroimmunol. 1998. PMID: 9670853

10

Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy.

Naumann U, Weller M. Naumann U, et al. Among authors: weller m. Int J Cancer. 1998 Aug 12;77(4):645-8. doi: 10.1002/(sici)1097-0215(19980812)77:4<645::aid-ijc27>3.0.co;2-3. Int J Cancer. 1998. PMID: 9679771 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,668 results

Search Page